Home
Momenta Pharmaceuticals

Momenta Pharmaceuticals Market Share Analysis for July 2026

Health > Biotechnology and Pharmaceuticals

Domainmomentapharma.com

Year Founded2001

Employees51 - 200

Annual Revenue$50M - $75M

Momenta Pharmaceuticals

Momenta Pharmaceuticals (including company regionals)

momentapharma.com

See more website traffic and engagement information

Momenta Pharmaceuticals Revenue up to July 2026 is 50M - 75M

revenue generated by Momenta Pharmaceuticals top domains

Momenta Pharmaceuticals top domains revenue over 3 years

Revenue for Momenta Pharmaceuticals top domains

momentapharma.com50M - 75M

See more with Sales Intelligence

Total visits to Momenta Pharmaceuticals's top domains

Understand Momenta Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

momentapharma.com254

See more with Sales Intelligence

Avg. visit duration in Momenta Pharmaceuticals's top domains

Analyze Momenta Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

momentapharma.com--

See more with Sales Intelligence

Avg. pageviews on Momenta Pharmaceuticals's top domains

See how Momenta Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

momentapharma.com1.08

See more with Sales Intelligence

Momenta Pharmaceuticals top competitors by domain

Top similar sites in July 2026, ranked by their affinity

proteontherapeutics.comCompany NameProteon TherapeuticsEmployees51 - 200HQUnited States, Massachusetts, WalthamAnnual revenue--Total visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Momenta Pharmaceuticals

These are the website technologies, by industry, used by Momenta Pharmaceuticals top domains

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

Email Services (2)

Microsoft Exchange Online

Marketing (2)

Google Marketing Platform

More Technologies

6

See all

News & Signals from Momenta Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAnthony Manning left Momentapharma as chief scientific officer on Jul 14th '26.Anthony Manning, Ph.D., former chief scientific officer of Momenta Pharmaceuticals, will chair the advisory board.

NewsMomentapharma signs new client BMW.BMW has selected Chinese technology firm Momenta to develop advanced driver-assistance systems (ADAS) for its upcoming Neue Klass electric vehicles (EVs), according to a report by Tencent News.

NewsBuick partnered with Momentapharma on Jan 1st '25.Carscoops can also expect advanced driver assistance systems as Buick is partnering with Momenta to deploy a Level 2 "urban driver assistance technology" starting in 2025.